Curaleaf (OTCMKTS:CURLF – Get Free Report) announced its quarterly earnings results on Monday. The company reported $0.02 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.09, Zacks reports. Curaleaf had a negative return on equity of 13.67% and a negative net margin of 14.82%.
Curaleaf Trading Down 9.9 %
OTCMKTS CURLF opened at $1.18 on Tuesday. The company has a market capitalization of $779.54 million, a PE ratio of -4.07 and a beta of 0.60. The company has a fifty day moving average of $1.45 and a 200 day moving average of $2.20. Curaleaf has a 1 year low of $0.88 and a 1 year high of $6.40. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.11 and a quick ratio of 0.51.
Wall Street Analysts Forecast Growth
Several analysts recently weighed in on CURLF shares. Cormark downgraded Curaleaf from a “moderate buy” rating to a “hold” rating in a research note on Thursday, November 7th. Roth Capital raised Curaleaf to a “strong-buy” rating in a report on Sunday, November 10th.
Curaleaf Company Profile
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
See Also
- Five stocks we like better than Curaleaf
- Which Wall Street Analysts are the Most Accurate?
- Warren Buffett Sold ULTA Stock—But Should You?
- Ride Out The Recession With These Dividend Kings
- 3 Actively Managed ETFs Outperforming Despite Their Higher Fees
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Monster Beverage: Monster Upside or a Risky Buy?
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.